199 related articles for article (PubMed ID: 36224354)
1. Mass spectrometry imaging discriminates glioblastoma tumor cell subpopulations and different microvascular formations based on their lipid profiles.
O'Neill KC; Liapis E; Harris BT; Perlin DS; Carter CL
Sci Rep; 2022 Oct; 12(1):17069. PubMed ID: 36224354
[TBL] [Abstract][Full Text] [Related]
2. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
Fabris D; Rožman M; Sajko T; Vukelić Ž
Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
[TBL] [Abstract][Full Text] [Related]
3. Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells.
He H; Conrad CA; Nilsson CL; Ji Y; Schaub TM; Marshall AG; Emmett MR
Anal Chem; 2007 Nov; 79(22):8423-30. PubMed ID: 17929901
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides of Human Glioblastoma Multiforme: A Comprehensive Mapping and Structural Analysis by Ion Mobility Tandem Mass Spectrometry.
Sarbu M; Petrica L; Clemmer DE; Vukelić Ž; Zamfir AD
J Am Soc Mass Spectrom; 2021 May; 32(5):1249-1257. PubMed ID: 33900081
[TBL] [Abstract][Full Text] [Related]
5. Aberrant fatty acyl alpha-hydroxylation in human neuroblastoma tumor gangliosides.
Ladisch S; Sweeley CC; Becker H; Gage D
J Biol Chem; 1989 Jul; 264(20):12097-105. PubMed ID: 2745431
[TBL] [Abstract][Full Text] [Related]
6. 1H NMR ganglioside ceramide resonance region on the differential diagnosis of low and high malignancy of brain gliomas.
Lombardi V; Valko L; Valko M; Scozzafava A; Morris H; Melnik M; Svitel J; Budesinský M; Pelnár J; Steno J; Liptaj T; Zalibera L; Budinská J; Zlatos J; Giuliani A; Mascolo L; Leibfritz D; Troncone A; Marzullo F; Mazur M; Klener J; Zverina E
Cell Mol Neurobiol; 1997 Oct; 17(5):521-35. PubMed ID: 9353593
[TBL] [Abstract][Full Text] [Related]
7. [Lipid composition of human malignant brain tumors].
Nakamura O; Ishihara E; Iwamori M; Nagai T; Matsutani M; Nomura K; Takakura K
No To Shinkei; 1987 Mar; 39(3):221-6. PubMed ID: 3034315
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence.
Fabris D; Karmelić I; Muharemović H; Sajko T; Jurilj M; Potočki S; Novak R; Vukelić Ž
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445547
[TBL] [Abstract][Full Text] [Related]
9. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
[TBL] [Abstract][Full Text] [Related]
10. Subventricular zone lipidomic architecture loss in Huntington's disease.
Hunter M; Demarais NJ; Faull RLM; Grey AC; Curtis MA
J Neurochem; 2018 Sep; 146(5):613-630. PubMed ID: 29804301
[TBL] [Abstract][Full Text] [Related]
11. Influence of Serum and Hypoxia on Incorporation of [(14)C]-D-Glucose or [(14)C]-L-Glutamine into Lipids and Lactate in Murine Glioblastoma Cells.
Ta NL; Seyfried TN
Lipids; 2015 Dec; 50(12):1167-84. PubMed ID: 26537505
[TBL] [Abstract][Full Text] [Related]
12. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
Sandhoff R; Sandhoff K
Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors.
Dyatlovitskaya EV; Andreasyan GO; Malykh YaN ; Rylova SN; Somova OG
Biochemistry (Mosc); 1997 May; 62(5):557-61. PubMed ID: 9275295
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers.
Shaner RL; Allegood JC; Park H; Wang E; Kelly S; Haynes CA; Sullards MC; Merrill AH
J Lipid Res; 2009 Aug; 50(8):1692-707. PubMed ID: 19036716
[TBL] [Abstract][Full Text] [Related]
15. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
16. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
[TBL] [Abstract][Full Text] [Related]
17. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
[TBL] [Abstract][Full Text] [Related]
18. Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits.
Bojic LA; McLaren DG; Shah V; Previs SF; Johns DG; Castro-Perez JM
Int J Mol Sci; 2014 Dec; 15(12):23283-93. PubMed ID: 25517033
[TBL] [Abstract][Full Text] [Related]
19. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
20. Membrane lipids modifications in human gliomas of different degree of malignancy.
Campanella R
J Neurosurg Sci; 1992; 36(1):11-25. PubMed ID: 1323645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
